The aim of the current study is to examine whether homebased step exercise at anaerobic threshold (AT) and branchedchain amino acid (BCAA) supplementation improve aerobic capacity, ectopic fat in liver and muscle, and glycemic control in patients with liver cirrhosis.
INTRODUCTION

P HYSICAL EXERCISE INTOLERANCE
1-3 and insulin resistance or impaired glycemic control 4, 5 are common in patients with liver cirrhosis. Although there are several reports on the effects of exercise training combined with diet modification in subjects with chronic liver disease (CLD), which include cirrhosis patients as a subset of all subjects, [6] [7] [8] to our knowledge, there are only two exercise studies that focus on patients with cirrhosis. One study with a small number of patient subjects (n = 4) showed that moderate cycle ergometer or treadmill training for 4-5 weeks did not alter the subjects' aerobic capacity, 3 whereas another study showed that a 12-week exercise program combined with leucine supplementation significantly increased the subjects' aerobic capacity. 9 The effects of long-term exercise training on aerobic fitness, ectopic fat accumulation, and insulin resistance (or glycemic control) in such patients has never been studied. Moderate exercise at the anaerobic threshold (AT) has been shown to safely increase the aerobic capacity in healthy individuals, elderly individuals, and patients with hypertension and coronary artery disease. [10] [11] [12] [13] As homebased bench step exercise at the AT offered a practical approach with a high level of compliance among elderly subjects, 14 we used this training regimen in the present study. Additionally, supplementation with branchedchain amino acids (BCAA) has been reported to increase the liver production of albumin and to improve insulin resistance and the health-related quality of life (HRQOL) in patients with cirrhosis. [15] [16] [17] [18] [19] The aim of the current study was to examine the effects of a long-term (12-month) program of home-based step exercise at the AT combined with BCAA supplementation on aerobic capacity, ectopic fat accumulation in the liver, and muscle and glycemic control in patients with liver cirrhosis.
METHODS
Patients
N
INE PATIENTS WITH liver cirrhosis (female, n = 8; male, n = 1; age, 51-79 years), who underwent treatment at Saga Medical School Hospital (Saga, Japan), were included in the current study. Liver cirrhosis was diagnosed based on a histological examination and/or clinical, biochemical, and imaging findings. Patients were excluded according to the following criteria: congenital BCAA metabolism abnormalities, poorly controlled diabetes or concomitant corticosteroid therapy, enteral nutrition within the previous 3 months, hepatocellular carcinoma, Child-Pugh class B or C disease, or an inability to undertake exercise. Cirrhosis patients who had received BCAA before the commencement of the present study were not excluded. Before beginning the study, written informed consent was obtained from all subjects, and the study was approved by the ethics committee of the Saga Medical School in accordance with the Helsinki Declaration (approval ID number: 2012-01-01).
Laboratory investigations
Venous blood was drawn from each patient after overnight fasting before and after 6 and 12 months of the exercise and BCAA intervention. The clinical biochemical parameters were measured according to the standard methods. The homeostasis model assessment of insulin resistance value was calculated as the product of the glucose (mg/ dL) and insulin (μIU/mL) divided by 405. 20 Absolute values of glycated albumin (GA) are apparently higher than the real values due to the prolonged half-life of albumin in patients with liver cirrhosis and CLD. 21 However, as GA was strongly associated with mean plasma glucose levels among patients with CLD 21 and because the albumin indices (serum albumin and prealbumin) were not affected by the 12-month intervention of the current study, we used GA as an index to reflect the relative changes in the glycemia throughout the study period. Additionally, CLD-hemoglobin A 1c (HbA lc ) was also calculated, as this index has been proposed as a superior indicator of chronic or long-term glycemic control status than HbA lc or GA alone in CLD patients, including patients with liver cirrhosis. 22 
Procedures
The subjects received BCAA orally (12.45 g/day [4.15 g × 3] ) and were instructed to carry out bench step exercises at an exercise intensity that corresponded to their AT, with a goal of performing 140 min of exercise per week at home for 12 months. Regarding dietary intake, a specific route of dietary intake or compositions was not recommended by the physician. However, to investigate the effects of exercise and BCAA intervention per se (independent of weight loss), all of the patients were asked not to change and simply to maintain their usual dietary habits before the commencement of the intervention (except for BCAA intake) throughout the 12-month study. The subjects were examined at baseline and at 6 and 12 months after the start of the intervention. The body weight and percentage of fat were measured by a body composition analyzer (ZEUS 9.9 PLUS; Kobe Medi-care Inc., Kobe, Japan). The body mass index was calculated by dividing the body weight (kg) by the square of the height (m 2 ). The visceral fat area and fat deposition in the liver (fat in the liver to spleen [L/S] ratio) and skeletal muscle (intramuscular adipose tissue content [IMAC] in the lumber multifidus muscle) were measured by computed tomography, as previously described. 23 Graded incremental exercise test using a bench step Submaximal incremental exercise tests were carried out using a bench step to measure lactate threshold, as an index of aerobic capacity and the exercise intensity used in the home-based exercise, as previously described. 14, 24 Metabolic equivalents (Mets) were calculated by dividing the estimated oxygen consumption during step exercises by the oxygen consumption at rest (which is assumed to be 3.5 mL/kg/min). The subjects were instructed to undertake bench step exercises at the AT, with a goal of performing 140 min of exercise per week at home, using a bench step (bench height 15-20 cm) and a compact disc that provides a regular rhythm set at the individual's AT. Group exercise sessions were carried out once a month at Saga Medical School Hospital by an exercise leader in order to maintain the subjects' motivation for continuing the exercise training. The average length of time spent on the bench step training (based on self-reported exercise
Hepatology Research 2017; 47: E193-E200 logs) was 151 ± 49 min/week over the 12-month intervention period.
Assessments of physical activity and HRQOL
Habitual physical activity was measured objectively using a uniaxial accelerometer (Lifecorder; Suzuken Inc., Nagoya, Japan), as previously described. 25 The physical activity level was calculated as the total energy expenditure divided by the basal metabolic rate. The subjects' HRQOL was assessed using a validated Short Form-8 questionnaire.
26-28
Statistical analysis
Three of the nine participants were excluded (one male and two females) because post-intervention data were not obtained for the data analysis. One male patient was newly diagnosed with a hepatocellular carcinoma at 3 months after the commencement of the study. One female had to stop the exercise training due to lower back pain that was unrelated to the current exercise program, and another female participant dropped out of the study due to personal reasons. Consequently, six female patients (hepatitis B surface antigen positive, n = 2; anti-hepatitis C virus antibody positive, n = 4) were included in the analysis. Among the six patients, only one had fatty liver (L/S ratio at study entry, 0.99) according to an L/S ratio <1.0 cut-off for the diagnosis of fatty liver, 29 and none had high baseline IMAC according to an IMAC > À0.31 cut-off for the assignment of high IMAC in female patients. 30 Comparisons of the data at baseline and after 6 and 12 months of the intervention were carried out using the nonparametric Wilcoxon signed-rank test, as the sample size (n = 6) was too small to assume a normal distribution of the parameters measured. To examine the effects of the 12-month exercise program, as a first step the data were compared at baseline and after the 12-month training program (as the primary end-point). Additional comparisons (secondary end-point, baseline vs. 6 months) were also carried out only when a significant difference between the data at baseline and after the 12-month intervention was detected. As the data on the L/S ratio and IMAC after the 12-month training were missing in one subject, the unmeasured data at 12 months were replaced by the data measured at 6 months in the same subject. This data replacement did not influence the main results or conclusions. The significance of the correlations between two variables was analyzed using Spearman's rank correlation coefficient. The percent change from baseline was calculated as the value after the intervention/value before the intervention ×100. All statistical analyses were carried out using the SAS software program (version 9.3 for Windows; SAS Institute, Cary, NC, USA). P-values <0.05 were considered to indicate statistical significance.
RESULTS
Changes in clinical parameters
N O SIGNIFICANT CHANGES were observed in body mass index, percent fat, visceral fat area, L/S ratio, or IMAC, the biochemical parameters of liver function, or the serum lipid levels after the exercise intervention ( Table 1) .
Changes in aerobic capacity, habitual physical activity, and HRQOL
The baseline aerobic capacity level assessed by the lactate threshold in the cirrhosis subjects was lower than that previously observed in healthy elderly females (4.2 ± 0.3 Mets).
14 There was a significant 39% increase in the subjects' aerobic capacity after the 12-month intervention (Table 1) . However, the indices of daily physical activity (Table 1 ) and eight HRQOL subscales (Table 2) did not change to a statistically significant extent during the intervention.
Changes in glycemic control indices and associations between baseline levels of body fat, ectopic fat, or serum TG and changes in indices of glycemic control
The decreases in the homeostasis model assessment of insulin resistance and HbA 1c values after the exercise did not reach statistical significance (Fig. 1a,b) . Another glycemic control index, GA, significantly decreased, whereas the CLD-HbA lc showed a similar tendency to decrease (P < 0.1) after the 12-month intervention (Fig. 1c,d) . No significant associations were observed between the baseline levels of percent body fat (Fig. 2a,b) , liver fat (L/S ratio) (Fig. 2c,d ), or skeletal muscle fat (IMAC) (Fig. 2e,f) and the 12-month changes in glycemic control indices (GA and CLD-HbA lc ). In contrast, the baseline TG level was significantly associated with the change in GA after the 12-month intervention (Fig. 2g) . A similar tendency (P < 0.1) was also observed with regard to the change in CLD-HbA lc (Fig. 2h) . No significant associations were observed between baseline levels of GA or CLD-HbA lc and the 12-month changes in GA (ρ = À0.03, P = 0.96) or CLD-HbA lc (ρ = À0.14, P = 0.79), respectively.
DISCUSSION
A EROBIC CAPACITY IS dependent on the skeletal muscle mitochondria 31 and a higher mitochondrial Moderate step exercise for cirrhosis patients E195 Hepatology Research 2017; 47: E193-E200 content is associated with higher whole-body insulin sensitivity. 32 Exercise training at the AT has been shown to induce a number of mitochondrial genes in human skeletal muscle. 33 Thus, we hypothesize that the current bench step exercise at the AT might increase muscle mitochondria even in patients with liver cirrhosis, and that the presumable increase in the muscle mitochondria could contribute to improved aerobic fitness and glycemic control after exercise. Additionally, a previous review reported that leucine, which is one of the components of BCAA, can increase muscle protein synthesis and stimulate pancreatic β-cells to release insulin. 34 Therefore, BCAA supplementation might also partly contribute to such improvements.
Lower levels of baseline liver fat (as indicated by a higher L/S ratio) are likely associated with greater improvements in the glycemic control indices, although these correlations did not reach statistical significance, probably due to the small sample size, as shown in Figure 2(c,d) . Excessive TG accumulation in the liver is known to be associated with an impaired ability to export hepatic TG into the circulation in the form of TG-rich lipoproteins, such as very low-density lipoprotein and chylomicrons. 35 Thus, similar Data are expressed as the medians and interquartile ranges. ‡Based on five subjects. †P-value for comparison between baseline value and after 12 months of intervention. §Statistically significant difference (P < 0.05) between the baseline and after 6 months of intervention. ALT, alanine aminotransferase; AT, anaerobic threshold; BCAA, branched-chain amino acid; BMI, body mass index; BTR, BCAA to tyrosine ratio; FPG, fasting plasma glucose; HDL-C, high density lipoprotein cholesterol; IMAC, intramuscular adipose tissue content; LDL-C, low density lipoprotein cholesterol; L/S ratio, liver to spleen ratio; Mets, metabolic equivalents; PAL, physical activity level; TC, total cholesterol; TG, triglyceride; VFA, visceral fat area.
to the abovementioned correlation analyses using the baseline L/S ratio as an independent variable, we attempted to examine whether or not the baseline serum TG is associated with the change in glycemic control with the current intervention. We found that a higher baseline serum TG (within normal range) was significantly associated with a greater improvement in glycemic control, as shown in Figure 2(g,h) . Namely, patients with a relatively high baseline TG may be able to expect a greater beneficial effect of the BCAA and exercise intervention than those with a relatively low baseline level. However, the current study cannot exclude the possibility that unmeasured factors other than the serum baseline TG (e.g. dietary intake) might contribute to the beneficial effects on glycemic control. It has been reported that apolipoprotein B and microsomal triglyceride transfer protein are necessary for the assembly of very low-density lipoprotein particles in liver cells and their secretion into circulation. 35, 36 We therefore speculate that the preserved quality and/or amount of these two factors (i.e. apolipoprotein B and microsomal triglyceride transfer protein) in the liver may be involved in the beneficial effects of the BCAA and exercise intervention. The precise and detailed mechanism underlying the associations between the baseline serum TG and glycemic indices in cirrhosis patients remains to be clarified. It should be considered that exercise training may have harmful effects. The current exercise program did not worsen the clinical data that reflect liver function, such as alanine aminotransferase and albumin, nor did we observe any other detrimental effects, such as knee pain or lower back pain. One concern is that there was a tendency for the prothrombin time to decrease after exercise, indicating a need for further careful investigation.
The present study is associated with several limitations. We cannot rule out the possibility that the current exercise program would significantly improve the glycemic indices if we had been able to investigate a greater number of patients. Additionally, the negative results on HRQOL could be due to its high level even before intervention, but it may also have been noted by chance, because of the small sample size. Moreover, the patients in our pilot study were only women; thus, the current results are not generalizable to male cirrhosis patients.
In conclusion, home-based step exercise at the AT together with BCAA supplementation for 12 months increased aerobic capacity and potentially improved the glycemic control in female liver cirrhosis patients without changes in body weight. In addition to home-based exercise, BCAA may also, in part, contribute to such beneficial effects. We did not observe any detrimental effects of the current exercise program, except a tendency for the prothrombin time to decrease. Moreover, relatively high levels of baseline serum TG may be linked to a greater improvement in glycemic control. The improvement of aerobic fitness and glycemic control through home-based training combined with BCAA is therefore considered to be a fruitful method for preventing glucose intolerance and complications of type 2 diabetes in patients with liver cirrhosis.
